TJX compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name

TJXTJX Companies Inc

Mkt capRevenueRevenue

AZNAstrazeneca PLC

Mkt capRevenueRevenue

Compare

TJXTJX Companies Inc

AZNAstrazeneca PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AZN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TJX 10

BRXBrixmor Propertysupplier

ADCAgree Realtysupplier

PECOPhillips Edisonsupplier

UEUrban Edge Propertiessupplier

6 more · TJX chain ›

Shared 0

No shared counterparties.

Only AZN 20

ARQTArcutis Biotherapeuticscustomer

GRALGrailsupplier

RCUSArcus Biosciencescustomer

NKTRNektar Therapeuticssupplier

Role chip = supplier or customerSource: SEC EDGAR

16 more · AZN chain ›

Price

rebased to 0%

TJX, solidAZN, dashed

TJXTJX Companies Inc

140.29▼−0.78%· post 140.31

Mkt cap$154.3BRevenue$15.2BQ2 FY27Revenue$60.4BFY26

AZNAstrazeneca PLC

186.63▲+7.01%· post 186.35

ClosedOct 30 '26

Mkt cap$289.5BRevenue—Revenue—

Compare

ClosedOct 30 '26

TJXTJX Companies Inc

AZNAstrazeneca PLC

140.29▼−0.78%post 140.31

Price

186.63▲+7.01%post 186.35

$154.3B

Mkt cap

$289.5B

Q2 FY27$15.2B

Revenue

—

FY26$60.4B

Revenue

—

TJX140.29▼−0.78%vsAZN186.63▲+7.01%ClosedOct 30 '26